Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by P. Disperati
Activity of the Janus Kinase Inhibitor Ruxolitinib in Chronic Lymphocytic Leukemia: Results of a Phase II Trial
Haematologica
Hematology
Related publications
Persistent Janus Kinase-Signaling in Chronic Lymphocytic Leukemia Patients on Ibrutinib: Results of a Phase I Trial
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
A Phase I/Ii Trial of TLR-7 Agonist Immunotherapy in Chronic Lymphocytic Leukemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Bruton's Tyrosine Kinase Inhibitor Restrains WNT Signaling in Chronic Lymphocytic Leukemia
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Azacitidine in Fludarabine-Refractory Chronic Lymphocytic Leukemia: A Phase II Study
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Gene Mutations and Treatment Outcome in Chronic Lymphocytic Leukemia: Results From the CLL8 Trial
Blood
Biochemistry
Immunology
Cell Biology
Hematology
A Phase I/Ii Study of Rituximab and Etanercept in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Duvelisib, an Oral Dual PI3K-δ,γ Inhibitor, Shows Clinical and Pharmacodynamic Activity in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma in a Phase 1 Study
American Journal of Hematology
Hematology
A Phase II Trial of Eltrombopag for Patients With Chronic Lymphocytic Leukaemia (CLL) and Thrombocytopenia
British Journal of Haematology
Hematology
the Specific Bruton Tyrosine Kinase Inhibitor Acalabrutinib (ACP-196) Shows Favorable in Vitro Activity Against Chronic Lymphocytic Leukemia B Cells With CD20 Antibodies
Haematologica
Hematology
